Data-driven phenomapping for novel classification for cardiovascular outcomes compared with traditional obesity index: Tehran Lipid and Glucose Study

Data-driven phenomapping for novel classification for cardiovascular outcomes compared with traditional obesity index: Tehran Lipid and Glucose Study

Objective This study aimed to propose a data-driven framework for classification of at-risk people for cardiovascular outcomes regarding obesity and metabolic syndrome.Design A population-based prospective cohort study with a long-term follow-up.Setting Data from the Tehran Lipid and Glucose Study (...

Full description

Bibliographic Details
Main Authors:	Davood Khalili, Yadollah Mehrabi, Elahe Zare Borzeshi, Majid Valizadeh, Mohammad Hossein Panahi, Mostafa Mousavizadeh
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-06-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/13/6/e071011.full

Similar Items

Effects of Lifestyle Modification Education on Prevalence of General and Central Obesity in Adults: Tehran Lipid and Glucose Study, Iran
by: Farzaneh Mobasheri, et al.
Published: (2012-11-01)

Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study
by: Maryam Kabootari, et al.
Published: (2018-02-01)

Patterns of change in obesity indices and other cardiometabolic risk factors before the diagnosis of type 2 diabetes: two decades follow-up of the Tehran lipid and glucose study
by: Fatemeh Koohi, et al.
Published: (2022-11-01)

Phenomapping approach to interpreting coronary dimensions in febrile children
by: Haoxun Tang, et al.
Published: (2022-12-01)

BMI variability and incident diabetes mellitus, Tehran Lipid and Glucose Study (TLGS)
by: Ladan Mehran, et al.
Published: (2022-11-01)

Determining the Factors Associated with Cardiovascular Disease Recurrence: Tehran Lipid and Glucose Study
by: Samira Taravatmanesh, et al.
Published: (2017-06-01)

Phenomapping chest pain: analyses from the PROMISE and ROMICAT-II cohorts
by: Matthew W. Segar, MD, MS, et al.
Published: (2020-09-01)

Sudden cardiac death among Iranian population: a two decades follow-up of Tehran lipid and glucose study
by: Hossein Toreyhi, et al.
Published: (2021-08-01)

Direct Estimate of Population Attributable Fraction of Risk Factors for Cardiovascular Diseases: Tehran Glucose and Lipid Study
by: SS Azimi, et al.
Published: (2012-03-01)

Development and validation of a continuous metabolic syndrome severity score in the Tehran Lipid and Glucose Study
by: Mohammadjavad Honarvar, et al.
Published: (2023-05-01)

Optimizing cardiovascular disease mortality prediction: a super learner approach in the tehran lipid and glucose study
by: Parvaneh Darabi, et al.
Published: (2024-04-01)

Crop-specific phenomapping by fusing Landsat and Sentinel data with MODIS time series
by: Jonas Schreier, et al.
Published: (2021-02-01)

County-level phenomapping to identify disparities in cardiovascular outcomes: An unsupervised clustering analysis
by: Matthew W. Segar, et al.
Published: (2020-12-01)

The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study
by: Rahele Rasooli, et al.
Published: (2022-12-01)

Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II
by: Hedayati Mehdi, et al.
Published: (2009-01-01)

Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study
by: Samaneh Asgari, et al.
Published: (2022-10-01)

Predisposing factors of long-term responsiveness in a cardio-metabolic cohort: Tehran Lipid and Glucose Study
by: Leila Cheraghi, et al.
Published: (2021-08-01)

Association between metabolic phenotypes and incident pre-sarcopenia: 3 years follow-up of Tehran Lipid and Glucose Study
by: Behnaz Abiri, et al.
Published: (2024-11-01)

The difference between 2-hour post-challenge and fasting plasma glucose associates with the risk of cardiovascular disease in a normoglycemic population: the Tehran lipid and glucose study
by: Amir Abdi, et al.
Published: (2024-02-01)

Multimodal Phenomap of Stargardt Disease Integrating Structural, Psychophysical, and Electrophysiologic Measures of Retinal Degeneration
by: Mya Abousy, BA, et al.
Published: (2024-01-01)

Phenomapping in patients experiencing worsening renal function during hospitalization for acute heart failure
by: Ryuichiro Yagi, et al.
Published: (2021-12-01)

12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study.
by: SeyedHossein Rabani, et al.
Published: (2018-01-01)

Weight change and risk of incident type 2 diabetes: short, medium and long-term follow-up in tehran lipid and glucose study
by: Samaneh Asgari, et al.
Published: (2024-06-01)

Association between lifetime endogenous estrogen exposure and body composition metrics in postmenopausal women: findings from the Tehran Lipid and Glucose Study
by: Elahe Rashidi, et al.
Published: (2024-12-01)

Validation of the Framingham hypertension risk score in a middle eastern population: Tehran lipid and glucose study (TLGS)
by: Fatemeh Koohi, et al.
Published: (2021-04-01)

A 10-Year Cardiovascular Risk in Adults with Different Levels of Spiritual Health: Tehran Lipid and Glucose Study
by: Parisa Amiri, et al.
Published: (2023-01-01)

The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study
by: Farzad Hadaegh, et al.
Published: (2021-01-01)

Factors associated with smoking intensity among adult smokers: findings from the longitudinal cohort of the Tehran lipid and glucose study
by: Marjan Abbasi-Dokht-Rafsanjani, et al.
Published: (2023-12-01)

Health-related quality of life in men and women who experienced cardiovascular diseases: Tehran Lipid and Glucose Study
by: Sara Jalali-Farahani, et al.
Published: (2021-09-01)

Identifying Factors Related to Serum Lipids Using Multilevel Quantile Model: Analysis of Nationwide STEPs Survey 2016
by: Parisa Mohseni, et al.
Published: (2023-05-01)

Trend analysis, gender-specific patterns, and age dynamics of childhood and adolescent obesity: insights from the Tehran lipid and glucose study
by: Behnaz Abiri, et al.
Published: (2024-10-01)

An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials
by: Evangelos K. Oikonomou, et al.
Published: (2023-11-01)

Higher ultra-processed food intake is associated with an increased incidence risk of cardiovascular disease: the Tehran lipid and glucose study
by: Mohammad Jalali, et al.
Published: (2024-03-01)

Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study
by: Fatemeh Koohi, et al.
Published: (2021-07-01)

Long-term incidence of cardiovascular outcomes in the middle-aged and elderly with different patterns of physical activity: Tehran lipid and glucose study
by: Parisa Naseri, et al.
Published: (2020-11-01)

The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999–2018
by: Fatemeh Koohi, et al.
Published: (2022-03-01)

Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study.
by: Farzad Hadaegh, et al.
Published: (2016-01-01)

Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study
by: Samaneh Asgari, et al.
Published: (2020-04-01)

Incidence of obesity and its predictors in children and adolescents in 10 years of follow up: Tehran lipid and glucose study (TLGS)
by: Maryam Barzin, et al.
Published: (2018-07-01)

The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
by: Farhad Hosseinpanah, et al.
Published: (2020-01-01)